Intuitive Surgical (ISRG) to Release Quarterly Earnings on Tuesday

Key Points

• Intuitive Surgical will release its Q1 2026 results after the market closes on Tuesday, April 21, with an earnings call at 4:30 PM ET; analysts expect EPS of $2.08 and revenue of $2.6216 billion.
• In the last reported quarter (Jan. 22) ISRG topped estimates with $2.53 EPS versus $2.27 expected and $2.87 billion in revenue (up 18.8% YoY), and analysts currently forecast about $6 EPS for the current fiscal year and $8 for the next.
• ISRG stock opened around $458.96 (market cap ~$163 billion) with a P/E of ~58, insiders sold roughly 32,943 shares (~$17.28M) in the past 90 days, and the consensus rating is a Moderate Buy with an average target of $604.73.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) is expected to be issuing its Q1 2026 results after the market closes on Tuesday, April 21st. Analysts expect the company to announce earnings of $2.08 per share and revenue of $2.6216 billion for the quarter. Parties are encouraged to explore the company's upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Tuesday, April 21, 2026 at 4:30 PM ET.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts' consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to analysts' expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company's quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.21 earnings per share. On average, analysts expect Intuitive Surgical to post $6 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Intuitive Surgical Stock Up 1.9%

ISRG stock opened at $458.96 on Tuesday. The stock has a market capitalization of $162.99 billion, a P/E ratio of 58.17, a P/E/G ratio of 3.52 and a beta of 1.68. The firm has a 50-day simple moving average of $480.39 and a 200-day simple moving average of $514.80. Intuitive Surgical has a 52 week low of $427.84 and a 52 week high of $603.88.

Insider Activity

In other news, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Fredrik Widman sold 133 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the sale, the vice president directly owned 660 shares of the company's stock, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 32,943 shares of company stock worth $17,279,568. Corporate insiders own 0.60% of the company's stock.

Institutional Trading of Intuitive Surgical

Hedge funds have recently made changes to their positions in the company. Strive Financial Group LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $40,000. Riggs Asset Managment Co. Inc. lifted its holdings in shares of Intuitive Surgical by 84.2% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider's stock worth $38,000 after acquiring an additional 32 shares during the last quarter. Birchwood Financial Partners Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $42,000. IFC & Insurance Marketing Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $45,000. Finally, JPL Wealth Management LLC acquired a new position in shares of Intuitive Surgical in the 3rd quarter worth approximately $45,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analyst Ratings Changes

Several brokerages recently issued reports on ISRG. UBS Group dropped their price objective on shares of Intuitive Surgical from $570.00 to $550.00 and set a "neutral" rating for the company in a research note on Tuesday, March 17th. TD Cowen raised shares of Intuitive Surgical to a "strong-buy" rating in a research note on Tuesday, January 27th. Raymond James Financial upped their price objective on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an "outperform" rating in a research note on Friday, January 23rd. Wall Street Zen cut shares of Intuitive Surgical from a "buy" rating to a "hold" rating in a research note on Saturday, February 7th. Finally, HSBC upped their price objective on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a "buy" rating in a research note on Monday, January 26th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average target price of $604.73.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.